VeriSign CapEx increased by 60.0% to $7.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 24.1%, from $5.80M to $7.20M. Over 4 years (FY 2021 to FY 2025), CapEx shows a downward trend with a -19.0% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $17.60M | $15.20M | $13.50M | $6.60M | $6.20M | $6.90M | $7.70M | $5.70M | $6.50M | $28.60M | $5.00M | $3.80M | $9.20M | $5.60M | $9.50M | $5.80M | $7.80M | $4.70M | $4.50M | $7.20M |
| QoQ Change | — | -13.6% | -11.2% | -51.1% | -6.1% | +11.3% | +11.6% | -26.0% | +14.0% | +340.0% | -82.5% | -24.0% | +142.1% | -39.1% | +69.6% | -38.9% | +34.5% | -39.7% | -4.3% | +60.0% |
| YoY Change | — | — | — | — | -64.8% | -54.6% | -43.0% | -13.6% | +4.8% | +314.5% | -35.1% | -33.3% | +41.5% | -80.4% | +90.0% | +52.6% | -15.2% | -16.1% | -52.6% | +24.1% |